Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

LONDON, September 22 /PRNewswire/ --

Optenet, a leading global IT security company and a provider of intelligent, integrated content security solutions, has become a member of the Internet Watch Foundation (IWF), joining over 80 member companies from a variety of organisations in their battle against illegal content online. With its web filtering expertise, Optenet aims to support the IWF's efforts to eliminate illegal Internet content, specifically, child sexual abuse images hosted anywhere in the world, as well as criminally obscene content and incitement to racial hatred content hosted in the UK.

AMSTERDAM, September 22 /PRNewswire/ -- Kiadis Pharma announced today that its lead product ATIR(TM) has been granted orphan drug designation (ODD) by the European Medicines Agency (EMEA) for the prevention of acute Graft versus Host Disease (GvHD) following an allogeneic bone marrow transplantation.

"Following the orphan drug designation granted by the FDA for our lead product ATIR(TM), this is another important milestone in the development of ATIR(TM) as a novel approach which may enable a safe and potentially life-saving mismatched bone marrow transplantation as a treatment option for end-stage blood cancer patients" says Dr. Manja Bouman, Chief Executive Officer of Kiadis Pharma.

WILMINGTON, Delaware, September 22 /PRNewswire/ --

- Improved Usability, New Style Checking Features, and Updates to the Grammar Checker Give Users a Complete Writing Solution

WhiteSmoke announces the immediate availability of WhiteSmoke 2009, the latest version of its desktop English writing application. WhiteSmoke 2009 is the premier writing tool for people who need quality written text, offering advanced grammar checking, style checking, and spell checking.

BRUSSELS, Belgium and PRINCETON, New Jersey, September 22 /PRNewswire/ -- GS1 is the global supply chain standards organisation well-known for its barcodes that feature on millions of products sold in retail. It has membership from over one million companies worldwide, particularly manufacturers and retailers of consumer packaged goods.

LONDON, September 22 /PRNewswire/ --

- Immediate Action Needed to Prepare for 100 Million Cases of Devastating Brain Disease Worldwide Expected by 2050(2)

LONDON, September 22 /PRNewswire/ --

- Asus Signs M-Commerce Deal With 2Shop4(TM)

2Shop4(TM), a text to shop mobile service, has brokered a pioneering deal with global technology giant Asus, which will change the way we shop. 2Shop4 offers a new and unique way of buying goods via a simple and secure text message whilst on the move.

The exciting new m-commerce development will launch in November 2008 and the signed deal with Asus, a leading provider of 3C (computers, communications and consumer electronics) total solutions will allow their products to be sold directly through advertisements or direct marketing as one of their first partners.